Results: 17,733,353
(searched for: doi:(10.1016/*))
Cancer Letters, Volume 497, pp 100-111; doi:10.1016/j.canlet.2020.10.016
The publisher has not yet granted permission to display this abstract.
Cancer Letters, Volume 497, pp 243-254; doi:10.1016/j.canlet.2020.10.034
The publisher has not yet granted permission to display this abstract.
Cancer Letters, Volume 497, pp 221-228; doi:10.1016/j.canlet.2020.10.039
Abstract:
Recent research on genomic profiling of pancreatic ductal adenocarcinoma (PDAC) has identified many potentially actionable alterations. However, the feasibility of using genomic profiling to guide routine clinical decision making for PDAC patients remains unclear. We retrospectively reviewed PDAC patients between October 2013 and December 2017, who underwent treatment at the Johns Hopkins Hospital and had clinical tumor next-generation sequencing (NGS) through commercial resources. Ninety-two patients with 93 tumors tested were included. Forty-eight (52%) patients had potentially curative surgeries. The median time from the tissue available to the NGS testing ordered was 229 days (interquartile range 62–415). A total of three (3%) patients had matched targeted therapies based on genomic profiling results. Genomic profiling guided personalized treatment for PDAC patients is feasible, but the percentage of patients who receive targeted therapy is low. The main challenges are ordering NGS testing early in the clinical course of the disease and the limited evidence of using a targeted approach in these patients. A real-time department level genomic testing ordering system in combination with an evidence-based flagging system for potentially actionable alterations could help address these shortcomings.
Physics Letters A, Volume 387; doi:10.1016/j.physleta.2020.127012
The publisher has not yet granted permission to display this abstract.
Physics Letters A, Volume 387; doi:10.1016/j.physleta.2020.127024
The publisher has not yet granted permission to display this abstract.
Physics Letters A, Volume 387; doi:10.1016/j.physleta.2020.127005
The publisher has not yet granted permission to display this abstract.
Physics Letters A, Volume 387; doi:10.1016/j.physleta.2020.127007
The publisher has not yet granted permission to display this abstract.
Physics Letters A, Volume 387; doi:10.1016/j.physleta.2020.127031
The publisher has not yet granted permission to display this abstract.
Physics Letters A, Volume 387; doi:10.1016/j.physleta.2020.127009
The publisher has not yet granted permission to display this abstract.
Physics Letters A, Volume 387; doi:10.1016/j.physleta.2020.127011
The publisher has not yet granted permission to display this abstract.
Physics Letters A, Volume 387; doi:10.1016/j.physleta.2020.127023
The publisher has not yet granted permission to display this abstract.
Physics Letters A, Volume 387; doi:10.1016/j.physleta.2020.127036
The publisher has not yet granted permission to display this abstract.
Physics Letters A, Volume 387; doi:10.1016/s0375-9601(20)30931-2
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140699
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140701
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140712
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140702
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140703
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140708
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140707
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140715
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140716
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140729
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140700
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140689
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140696
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2021.140768
Cancer Letters, Volume 497, pp 165-177; doi:10.1016/j.canlet.2020.10.021
The publisher has not yet granted permission to display this abstract.
Cancer Letters, Volume 497, pp 54-65; doi:10.1016/j.canlet.2020.10.003
The publisher has not yet granted permission to display this abstract.
Cancer Letters, Volume 497, pp 154-164; doi:10.1016/j.canlet.2020.10.020
Abstract:
Solid tumors are composed of tumor cells and stromal cells including lymphatic endothelial cells (LEC), which are mainly viewed as cells forming lymphatic vessels involved in the transport of metastatic and immune cells. We here reveal a new mechanism by which tumor exposed-LEC (teLEC) exert mitogenic effects on tumor cells. Our conclusions are supported by morphological and molecular changes induced in teLEC that in turn enhance cancer cell invasion in 3D cultures and tumor cell proliferation in vivo. The characterization of teLEC secretome by RNA-Sequencing and cytokine array revealed that interleukine-6 (IL6) is one of the most modulated molecules in teLEC, whose production was negligible in unexposed LEC. Notably, neutralizing anti-human IL6 antibody abrogated teLEC-mediated mitogenic effects in vivo, when LEC were mixed with tumor cells in the ear sponge assay. We here assign a novel function to teLEC that is beyond their role of lymphatic vessel formation. This work highlights a new paradigm, in which teLEC exert “fibroblast-like properties”, contribute in a paracrine manner to the control of tumor cell properties and are worth considering as key stromal determinant in future studies.
Physics Letters A, Volume 387; doi:10.1016/j.physleta.2020.127006
The publisher has not yet granted permission to display this abstract.
Physics Letters A, Volume 387; doi:10.1016/j.physleta.2020.127008
The publisher has not yet granted permission to display this abstract.
Physics Letters A, Volume 387; doi:10.1016/j.physleta.2020.127026
The publisher has not yet granted permission to display this abstract.
Physics Letters A, Volume 387; doi:10.1016/j.physleta.2020.127029
The publisher has not yet granted permission to display this abstract.
Physics Letters A, Volume 387; doi:10.1016/j.physleta.2020.127037
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140648
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140713
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140684
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140719
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140722
The publisher has not yet granted permission to display this abstract.
Materials Science and Engineering: A, Volume 803; doi:10.1016/j.msea.2020.140695
The publisher has not yet granted permission to display this abstract.
Cancer Letters, Volume 497, pp 77-88; doi:10.1016/j.canlet.2020.10.022
The publisher has not yet granted permission to display this abstract.
Cancer Letters, Volume 497, pp 137-153; doi:10.1016/j.canlet.2020.10.023
The publisher has not yet granted permission to display this abstract.
Cancer Letters, Volume 497, pp 28-40; doi:10.1016/j.canlet.2020.10.014
The publisher has not yet granted permission to display this abstract.
Cancer Letters, Volume 497, pp 212-220; doi:10.1016/j.canlet.2020.10.032
The publisher has not yet granted permission to display this abstract.
Cancer Letters, Volume 497, pp 229-242; doi:10.1016/j.canlet.2020.10.037
The publisher has not yet granted permission to display this abstract.
Physics Letters A, Volume 387; doi:10.1016/j.physleta.2020.127020
The publisher has not yet granted permission to display this abstract.
Physics Letters A, Volume 387; doi:10.1016/j.physleta.2020.127004
The publisher has not yet granted permission to display this abstract.
Physics Letters A, Volume 387; doi:10.1016/j.physleta.2020.127025
The publisher has not yet granted permission to display this abstract.
Physics Letters A, Volume 387; doi:10.1016/j.physleta.2020.127010
The publisher has not yet granted permission to display this abstract.